Presentation is loading. Please wait.

Presentation is loading. Please wait.

Would it be more beneficial to take aspirin in the evening for prevention of cardiovascular diseases?  Ildikó Kriszbacher, MSC, Miklós Koppán, MD, PhD,

Published byἜβέρ Μανιάκης Modified over 5 years ago

Similar presentations

Presentation on theme: "Would it be more beneficial to take aspirin in the evening for prevention of cardiovascular diseases?  Ildikó Kriszbacher, MSC, Miklós Koppán, MD, PhD,"— Presentation transcript:

1 Would it be more beneficial to take aspirin in the evening for prevention of cardiovascular diseases?  Ildikó Kriszbacher, MSC, Miklós Koppán, MD, PhD, József Bódis, MD, PhD, DSc  Journal of Vascular Surgery  Volume 41, Issue 2, (February 2005) DOI: /j.jvs Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

2 Fig Relation of plasma serum levels of salicylic acid and the daily distribution of the occurrence of myocardial infarction and of acute ischemic stroke. Vertical bar graphs represent daily distribution of the incidence of myocardial infarction and stroke.2,3 Line diagrams show the serum levels of salicylic acid in μg/mL taken at 10:00 pm (dotted line) and at 8:00 am (solid line). The maximum plasma concentration of salicylic acid occurs 3.5 to 4.0 hours after intake.4 •Myocardial infarct (n = 914), —stroke (n = 1741); n, total number of patients involved in analysis; SA, salicylic acid. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Download ppt "Would it be more beneficial to take aspirin in the evening for prevention of cardiovascular diseases?  Ildikó Kriszbacher, MSC, Miklós Koppán, MD, PhD,"

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages 1072-1082 (October 2014) DOI:

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
Patients with abdominal aortic aneurysm: Are we missing the opportunity for cardiovascular risk reduction?  G.M. Lloyd, MRCS, J.D. Newton, MRCP, M.G.A.

Patients with abdominal aortic aneurysm: Are we missing the opportunity for cardiovascular risk reduction?  G.M. Lloyd, MRCS, J.D. Newton, MRCP, M.G.A.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Without prejudice Journal of Vascular Surgery

Without prejudice Journal of Vascular Surgery
Louise C. Brown, PhD, B'Eng, MSc, Simon G. Thompson, DSc, MA, Roger M

Louise C. Brown, PhD, B'Eng, MSc, Simon G. Thompson, DSc, MA, Roger M
A patient with multiple paradoxical emboli

A patient with multiple paradoxical emboli
Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms  Nikolaj Eldrup, MD, PhD, Jacob.

Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms  Nikolaj Eldrup, MD, PhD, Jacob.
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation  Franklin A. Bontempo, MD, Andrea Cortese Hassett, PhD, Hawazin Faruki,

The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation  Franklin A. Bontempo, MD, Andrea Cortese Hassett, PhD, Hawazin Faruki,
Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis  Chalotte Winther Nicolajsen, MD, Maja.

Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis  Chalotte Winther Nicolajsen, MD, Maja.
Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from.

Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from.
Reference value of transcutaneous oxygen measurement in diabetic patients compared with nondiabetic patients  Vincent E. de Meijer, MD, MSc, Hans P. van't.

Reference value of transcutaneous oxygen measurement in diabetic patients compared with nondiabetic patients  Vincent E. de Meijer, MD, MSc, Hans P. van't.
Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation  Thomas M. Loh,

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation  Thomas M. Loh,
Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr
Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD 

Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD 
Mesenteric venous thrombosis with transmural intestinal infarction: A population-based study  Stefan Acosta, MD, PhD, Mats Ögren, MD, PhD, Nils-Herman.

Mesenteric venous thrombosis with transmural intestinal infarction: A population-based study  Stefan Acosta, MD, PhD, Mats Ögren, MD, PhD, Nils-Herman.
Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 

Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 
Silent myocardial ischemia in patients undergoing peripheral vascular surgery: Incidence and association with perioperative cardiac morbidity and mortality 

Silent myocardial ischemia in patients undergoing peripheral vascular surgery: Incidence and association with perioperative cardiac morbidity and mortality 
Effect of anticoagulation on endothermal ablation of the great saphenous vein  Mohsen Sharifi, MD, Mahshid Mehdipour, Curt Bay, PhD, Farnaz Emrani, BS,

Effect of anticoagulation on endothermal ablation of the great saphenous vein  Mohsen Sharifi, MD, Mahshid Mehdipour, Curt Bay, PhD, Farnaz Emrani, BS,
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,

Similar presentations

Ads by Google